Different initial steps of apoptosis induced by two types of antineoplastic drugs

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• Temozolomide (TMZ) and ACNU are antineoplastic drugs that induce distinct DNA lesions: O6-methylguanine and O6-chloroethylguanine, respectively.
• The DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT) repairs these lesions.
• Unrepaired lesions trigger apoptosis through different mechanisms, involving MLH1 and DNA replication.

Purpose of the Study:

• To elucidate the distinct pathways of apoptosis induced by TMZ and ACNU.
• To investigate the roles of MGMT, MLH1, and APAF-1 in drug-induced apoptosis.
• To compare the kinetics of apoptosis triggered by these two chemotherapeutic agents.

Main Methods:

• Utilizing cell lines with deficiencies in MGMT, MLH1, and APAF-1.
• Treating cells with TMZ and ACNU to observe DNA lesion formation and repair.
• Monitoring cellular events such as phosphatidylserine translocation, mitochondrial membrane potential changes, and apoptosis induction.

Main Results:

• O6-methylguanine lesions from TMZ induce apoptosis in an MLH1-dependent manner requiring DNA replication.
• O6-chloroethylguanine lesions from ACNU induce apoptosis independently of MLH1 and DNA replication.
• APAF-1 is essential for apoptosis execution induced by both TMZ and ACNU.
• Apoptosis-related mitochondrial depolarization is delayed by approximately 12 hours in TMZ-treated cells compared to ACNU-treated cells.

Conclusions:

• The mechanisms of apoptosis induced by TMZ and ACNU differ significantly, highlighting the importance of DNA repair pathways and replication.
• MLH1 and DNA replication are critical for TMZ-induced apoptosis, whereas ACNU-induced apoptosis proceeds via an MLH1- and replication-independent pathway.
• APAF-1 is a crucial effector in the apoptotic cascade initiated by both drugs.